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quantification the proper attenuation, scatter and 
partial volume corrections need to be applied. If organ 
or lesion dosimetry is performed, precise determination 
of organ/lesion volumes is necessary. Care has to be 
taken for an appropriate calibration of the imaging 
system. 
b) Biokinetics 
  This requires the determination of a correct temporal 
sampling and the use of ad hoc procedures to integrate 
the activity within time to obtain the total number of 
decays occurring in the source organs and thus the 
time-integrated activity coefficients (TIACs). 
c) Absorbed dose Calculation 
If the TIACs of the relevant structures are known, a 
calculation of the absorbed doses can be performed by 
applying, in most cases, the “MIRD formalism”: 
D = Ã*S 
D: the mean absorbed dose to a voxel or a target 
region from the cumulated activity in a source region. 
Ã: the cumulated activity (i.e. the integral of the 
time-activity curve) 
S: S factor (= mean absorbed dose per unit cumulated 
activity in the voxel or the target region).  
Different dose calculation approaches exist: These may 
either be based on tabulated S factors (with mass correction) 
of anthropomorphic phantoms, on convolution kernels or on 
Monte-Carlo simulations. 
Results: The most successful pairs of isotopes for theranostics 
are I-123/I-124/I-131 [2] and Ga-68/Lu-177/Y-90 [3]. In 
addition, Y-90 PET/CT provides a good estimate of the 
absorbed doses in selective internal radiotherapy for loco-
regional liver treatment [4]. 
 
Conclusion: Although many new radiopharmaceuticals are 
available for imaging and molecular radiotherapy it is still a 
challenge to establish reliable dose-response relationships.  
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Purpose: Auger-electron (AE) emitting radionuclides could be 
exploited for therapeutic purposes due to the high local 
energy deposition by low-energy Auger electrons or may 
deliver an unintentional mean absorbed dose burden when 
used as medical imaging agents. The aim of this study is to 
provide S-values for selected 14 AE emitting radionuclides 
based on the latest radiation spectra.  
Methods: The Monte Carlo code PENELOPE [1] was used to 
transport the complete radiation spectra of 67Ga, 80mBr, 89Zr, 
90Nb, 99mTc, 111In, 117mSn, 119Sb, 123I, 124I, 125I, 135La, 195mPt and 
201Tl using the methodology described in Ref. [2]. Radiation 
spectra was based on the unabridged nuclear decay data 
from MIRD RADTABS program [3] and the radiation spectra 
generated using the BrIccEmis code [4]. Taking the nucleus as 
the target, simulations were run assuming uniformly 
distributed activity in the nucleus (N←N), in the cytoplasm 
(N←Cy) or on the cell surface (N←CS).  
Results: A comparison of calculated Auger yields for all 14 
radionuclides is shown in the table below. Auger yields from 
MIRD are consistently higher than the values calculated using 
the BrIccEmis code. The methodology used to produce data 
in MIRD did not account for variations in binding energies 
during atomic relaxation thus overestimated the intensity of 
low-energy electrons.  
 
BrIccEmiss determined S-values were generally lower 
compared with MIRD S-values with the greatest differences 
noted when the source is far from the target region, i.e. for 
the N←Cy and N←CS configurations. 
Conclusions: Realistic modelling of atomic relaxation 
following nuclear decay is essential for producing the 
radiation spectra needed for the calculations of S-values.  
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Purpose: The local temperature increase induced by ion 
energy deposition in tissue creates an “ionoacoustic” 
ultrasound signal, particularly at the dose maximum (Bragg 
peak)[1-3]. This signal may be used for range verification in 
ion beam therapy in the future, which is still an important 
challenge for this irradiation modality. This approach has 
recently been revisited by several groups in simulations [4, 
5], and by our group in simulations and also in proof-of-
principle experiments with pulsed 20 MeV proton beams [6]. 
Here we present new simulations and first measurements of 
the ionoacoustic signal produced in water by proton beams 
accelerated up to energies of 227 MeV at a clinical synchro-
cyclotron. 
Material and Methods: In preparation of ionoacoustic 
experiments at clinically relevant energies, we extended our 
simulations from previously 20 MeV to beam energies of 120-
230 MeV. The propagation of ultrasound waves was simulated 
by the MATLAB toolbox k-Wave using Geant4 for calculations 
of the initial dose deposition. The corresponding 
experimental setup to measure the ionoacoustic signal 
consisted of a broadband hydrophone (500 Hz - 250 kHz) 
placed in a water phantom with protons entering through the 
water surface. We measured the transit time of the 
ionoacoustic signal from the Bragg peak to the hydrophone 
and varied this distance either by using different energies 
(227, 226 and 145 MeV) or by changing the detector position 
while using the maximum energy.  
Result: The simulations showed a distinct frequency shift of 
the ionoacoustic signal spectrum from a few MHz at 20 MeV 
from our previous experiments to about 100 kHz and below at 
proton beam energies above 120 MeV. At the new IBA 
synchro-cyclotron, we were able to measure ionoacoustic 
